Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients
Identifieur interne : 000C40 ( Istex/Curation ); précédent : 000C39; suivant : 000C41Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients
Auteurs : Mostafa A. Elgohary [Égypte] ; Jonathan G. DowlerSource :
- Clinical & Experimental Ophthalmology [ 1442-6404 ] ; 2006-08.
English descriptors
- KwdEn :
Abstract
Purpose: To estimate the cumulative incidence and identify the risk factors of posterior capsule opacification (PCO) that required Nd:YAG capsulotomy in non‐diabetic and diabetic patients. Methods: Retrospective case‐note review of 806 consecutive patients that underwent phacoemulsification and intraocular lens (IOL) implantation, 327 (40.6%) of whom were diabetic. Results: The cumulative incidence of Nd:YAG capsulotomy were 10.6%, 14.8%, 21.2% and 28.6% in non‐diabetic patients; and 9%, 9.4%, 15.3% and 5.3% in diabetic patients after 1, 2, 3 and 4 years, respectively. A multivariate Cox regression analysis showed that, over the follow‐up period, diabetes mellitus was associated with a decreased risk of Nd:YAG capsulotomy (hazard ratio [HR] = 0.69; 95% confidence interval [CI] 0.47–0.99; P = 0.047), whereas age of 65 years or younger (HR = 1.58; 95% CI 1.09–2.27; P = 0.02), polymethylmethacrylate (PMMA) (HR = 3.98; 95% CI 1.60–9.95; P = 0.003) or plate‐haptic silicone IOLs (HR = 3.75; 95% CI 1.60–8.80; P = 0.002) in comparison with three‐piece silicone IOLs, postoperative inflammation (HR = 2.62; 95% CI 1.56–4.42; P < 0.001) and pars plana vitrectomy (HR = 1.85; 95% CI 1.20–2.83; P = 0.005) were associated with an increased risk. Subgroup analysis showed that in non‐diabetic patients, male gender (HR = 1.63; 95% CI 1.04–2.57; P = 0.03) was an additional risk factor and in diabetic patients there was no significant association between diabetes type, duration or retinopathy grade and the risk of Nd:YAG capsulotomy. Conclusion: Although diabetes mellitus appears to be associated with a lower long‐term incidence and a decreased risk of Nd:YAG capsulotomy, younger age, pars plana vitrectomy, postoperative inflammation, plate‐haptic silicone and PMMA IOLs in addition to male gender in non‐diabetic patients appear to be associated with a greater risk. Estimation of the incidence and risk factors of PCO should help in patient counselling and to design methods to reduce or prevent its development.
Url:
DOI: 10.1111/j.1442-9071.2006.01263.x
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C40
Links to Exploration step
ISTEX:F6C4228C5A4E572E0AB6ECF415384BFDFE4473FECuration
No country items
Mostafa A. Elgohary<affiliation><mods:affiliation>Medical Retina Service, Moorfields Eye Hospital, London, UK; and</mods:affiliation>
<wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Tanta Ophthalmology University Hospital, Tanta, Egypt</mods:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Tanta Ophthalmology University Hospital, Tanta</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>Medical Retina Service, Moorfields Eye Hospital, London, UK; and</mods:affiliation>
<wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients</title>
<author><name sortKey="Elgohary, Mostafa A" sort="Elgohary, Mostafa A" uniqKey="Elgohary M" first="Mostafa A" last="Elgohary">Mostafa A. Elgohary</name>
<affiliation><mods:affiliation>Medical Retina Service, Moorfields Eye Hospital, London, UK; and</mods:affiliation>
<wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Tanta Ophthalmology University Hospital, Tanta, Egypt</mods:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Tanta Ophthalmology University Hospital, Tanta</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dowler, Jonathan G" sort="Dowler, Jonathan G" uniqKey="Dowler J" first="Jonathan G" last="Dowler">Jonathan G. Dowler</name>
<affiliation><mods:affiliation>Medical Retina Service, Moorfields Eye Hospital, London, UK; and</mods:affiliation>
<wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1111/j.1442-9071.2006.01263.x</idno>
<idno type="url">https://api.istex.fr/document/F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000C40</idno>
<idno type="wicri:Area/Istex/Curation">000C40</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients</title>
<author><name sortKey="Elgohary, Mostafa A" sort="Elgohary, Mostafa A" uniqKey="Elgohary M" first="Mostafa A" last="Elgohary">Mostafa A. Elgohary</name>
<affiliation><mods:affiliation>Medical Retina Service, Moorfields Eye Hospital, London, UK; and</mods:affiliation>
<wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1"><mods:affiliation>Tanta Ophthalmology University Hospital, Tanta, Egypt</mods:affiliation>
<country xml:lang="fr">Égypte</country>
<wicri:regionArea>Tanta Ophthalmology University Hospital, Tanta</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Dowler, Jonathan G" sort="Dowler, Jonathan G" uniqKey="Dowler J" first="Jonathan G" last="Dowler">Jonathan G. Dowler</name>
<affiliation><mods:affiliation>Medical Retina Service, Moorfields Eye Hospital, London, UK; and</mods:affiliation>
<wicri:noCountry code="subField">UK; and</wicri:noCountry>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Clinical & Experimental Ophthalmology</title>
<idno type="ISSN">1442-6404</idno>
<idno type="eISSN">1442-9071</idno>
<imprint><publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2006-08">2006-08</date>
<biblScope unit="volume">34</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="526">526</biblScope>
<biblScope unit="page" to="534">534</biblScope>
</imprint>
<idno type="ISSN">1442-6404</idno>
</series>
<idno type="istex">F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE</idno>
<idno type="DOI">10.1111/j.1442-9071.2006.01263.x</idno>
<idno type="ArticleID">CEO1263</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1442-6404</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Nd:YAG</term>
<term>capsulotomy</term>
<term>cataract</term>
<term>diabetes mellitus</term>
<term>incidence</term>
<term>intraocular</term>
<term>lens</term>
<term>phacoemulsification</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Purpose: To estimate the cumulative incidence and identify the risk factors of posterior capsule opacification (PCO) that required Nd:YAG capsulotomy in non‐diabetic and diabetic patients. Methods: Retrospective case‐note review of 806 consecutive patients that underwent phacoemulsification and intraocular lens (IOL) implantation, 327 (40.6%) of whom were diabetic. Results: The cumulative incidence of Nd:YAG capsulotomy were 10.6%, 14.8%, 21.2% and 28.6% in non‐diabetic patients; and 9%, 9.4%, 15.3% and 5.3% in diabetic patients after 1, 2, 3 and 4 years, respectively. A multivariate Cox regression analysis showed that, over the follow‐up period, diabetes mellitus was associated with a decreased risk of Nd:YAG capsulotomy (hazard ratio [HR] = 0.69; 95% confidence interval [CI] 0.47–0.99; P = 0.047), whereas age of 65 years or younger (HR = 1.58; 95% CI 1.09–2.27; P = 0.02), polymethylmethacrylate (PMMA) (HR = 3.98; 95% CI 1.60–9.95; P = 0.003) or plate‐haptic silicone IOLs (HR = 3.75; 95% CI 1.60–8.80; P = 0.002) in comparison with three‐piece silicone IOLs, postoperative inflammation (HR = 2.62; 95% CI 1.56–4.42; P < 0.001) and pars plana vitrectomy (HR = 1.85; 95% CI 1.20–2.83; P = 0.005) were associated with an increased risk. Subgroup analysis showed that in non‐diabetic patients, male gender (HR = 1.63; 95% CI 1.04–2.57; P = 0.03) was an additional risk factor and in diabetic patients there was no significant association between diabetes type, duration or retinopathy grade and the risk of Nd:YAG capsulotomy. Conclusion: Although diabetes mellitus appears to be associated with a lower long‐term incidence and a decreased risk of Nd:YAG capsulotomy, younger age, pars plana vitrectomy, postoperative inflammation, plate‐haptic silicone and PMMA IOLs in addition to male gender in non‐diabetic patients appear to be associated with a greater risk. Estimation of the incidence and risk factors of PCO should help in patient counselling and to design methods to reduce or prevent its development.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C40 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000C40 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Ticri/CIDE |area= HapticV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:F6C4228C5A4E572E0AB6ECF415384BFDFE4473FE |texte= Incidence and risk factors of Nd:YAG capsulotomy after phacoemulsification in non‐diabetic and diabetic patients }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |